Shanghai Haoyuan Chemexpress Co (SHSE:688131) Long-Term Capital Lease Obligation : ¥300 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Long-Term Capital Lease Obligation?

Shanghai Haoyuan Chemexpress Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥300 Mil.

Shanghai Haoyuan Chemexpress Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (¥348 Mil) to Dec. 2024 (¥295 Mil) but then increased from Dec. 2024 (¥295 Mil) to Mar. 2025 (¥300 Mil).

Shanghai Haoyuan Chemexpress Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (¥195 Mil) to Dec. 2023 (¥169 Mil) but then increased from Dec. 2023 (¥169 Mil) to Dec. 2024 (¥295 Mil).

Shanghai Haoyuan Chemexpress Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Long-Term Capital Lease Obligation Chart

Shanghai Haoyuan Chemexpress Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

81.74

165.50

194.93

168.86

295.21

Shanghai Haoyuan Chemexpress Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															159.70	181.00	347.98	295.21	299.57

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shanghai Haoyuan Chemexpress Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haoyuan Chemexpress Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.chemexpress.com.cn

Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.

Executives

Mei Kui

Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines